| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Biostatistics and Industrial Environmental Health Sciences, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania 15162
Genotoxic activities of a series of commercially purchased 1,N6-ethenoadenosine (
-Ado) and
-deoxyadenosine (
-dAdo) derivatives were assessed using the sister chromatid exchange (SCE) assay in murine spleen lymphocytes in vitro. Of the
-Ado adducts evaluated for SCE induction
-ATP and
-dATP were highly active (5x baseline) SCE inducers over a concentration range of 50150 µM. Moderate SCE-inducing activities were seen with
-dAdo,
-A, and
-AMP.
-A was of particular interest in that spleen lymphocytes from a single mouse were highly sensitive to SCE (>50 SCE/cell at 75 µM).
-Ado was weakly effective and
-ADP and
-dAMP did not produce significantly elevated SCEs. Cocanavalin A-stimulated T-lymphocytes and lipopolysaccharide-stimulated B-lymphocytes exhibited comparable SCE responses to
-A,
-AMP, and
-dATP. However, B-lymphocytes were considerably less sensitive than T-lymphocytes to
-dAdo and
-ATP.
Evaluation of the purities of specific
-Ado derivatives, as performed by high-performance liquid chromatography and thin layer chromatography, failed to detect potential contaminants as cytogenetically active agents. However, a difference (about threefold) in cytogenetic activities of two lot numbers of
-ATP paralleled the difference in UV absorbance of equivalent concentrations (mg/ml), prepared according to the manufacturers stated purity. Any impurities likely to be present were consistent with inactive nonchromophoric compounds such as buffer salts.
Because of the direct genotoxic activity of
-A in intact mammalian cells, we suggest that intracellular adenylate pools, including the prominent ubiquitous nucleotide ATP, are non-DNA targets for
-modification by active metabolites and the resulting
-adducts are likely to be active moieties in SCE induction and in neoplastic transformation produced by ethyl carbamate.
1 This research was supported in part by Research Grant R01-CA-39401-03 awarded to M. K. C. and by BRSG 2-SOT-RR05451-27 awarded by the Biomedical Research Support Grant Program, Division of Research Resources, NIH.
2 To whom requests for reprints should be addressed, at Genetic Toxicology, University of Pittsburgh, 732 Parran Hall, School of Public Health, Pittsburgh, PA 15261.
Received 12/12/88. Revised 3/31/89. Accepted 4/11/89.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |